Dr. Talia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5 E 98th St
New York, NY 10029
Summary
- Dr. Jordan Talia is a dermatologist based in New York, NY. He completed his education at the University of Michigan Medical School and his residency at the University of Michigan Health System followed by a specialty stint in Complex Medical Dermatology at Brigham and Women’s Hospital. He is currently employed at Mount Sinai Hospital Dermatology, having previously worked at Dermatology Specialists of Brighton. Dr. Talia has numerous published works in various esteemed journals including Clinical and Experimental Dermatology, JAMA Dermatology, Journal of the American Academy of Dermatology and Plastic and Reconstructive Surgery, some of which have been cited multiple times by other publications.
Education & Training
- Brigham and Women’s HospitalComplex Medical Dermatology, 2020 - 2021
- University of MichiganResidency, Dermatology, 2017 - 2020
- University of Michigan Medical SchoolClass of 2016
Certifications & Licensure
- MI State Medical License 2017 - 2027
- NY State Medical License 2023 - 2025
- MA State Medical License 2020 - 2021
- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- 1 citationsPembrolizumab-associated expansion of radiation-induced morphoea responsive to dupilumab: a case report.Jordan T Said, Christopher Iriarte, Jordan Talia, Bonnie Leung, Cesar A Virgen
Clinical and Experimental Dermatology. 2023-08-25 - 6 citationsImpact of biologic therapy on cancer outcomes in patients with immune checkpoint inhibitor-induced bullous pemphigoid.Jordan T Said, Jordan Talia, Erin Wei, Arash Mostaghimi, Yevgeniy Semenov
Journal of the American Academy of Dermatology. 2023-03-01 - 11 citationsRisk Factors for the Development of Bullous Pemphigoid in US Patients Receiving Immune Checkpoint Inhibitors.Jordan T Said, Mofei Liu, Jordan Talia, Sean B Singer, Yevgeniy R Semenov
JAMA Dermatology. 2022-05-01
Press Mentions
- Vitiligo: An Update on Treatment OptionsDecember 7th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: